Lini Pandite
Chief Tech/Sci/R&D Officer bei SHATTUCK LABS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Lini Pandite is an Independent Director at Codiak BioSciences, Inc. and Chief Medical Officer at Shattuck Labs, Inc. She previously worked as Vice President at GSK Plc from 2001 to 2015, and as Head-Global Clinical Development & Senior VP at Adaptimmune Therapeutics Plc from 2015 to 2017.
She also held a Vice President-Research & Development position at GlaxoSmithKline LLC.
Dr. Pandite holds a doctorate from The University of Liverpool and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SHATTUCK LABS, INC.
0,46% | 30.01.2024 | 216 360 ( 0,46% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Lini Pandite
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Chief Tech/Sci/R&D Officer | 01.07.2017 |
| CODIAK BIOSCIENCES | Director/Board Member | 16.08.2021 |
Ehemalige bekannte Positionen von Lini Pandite
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01.06.2017 |
| GSK PLC | Corporate Officer/Principal | 01.04.2015 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Lini Pandite
| The University of Liverpool | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GSK PLC | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
